EGFR and non-small cell lung carcinoma: This indicated that understanding the insights into the PAFR pathway and its crosstalk with potential signaling mechanisms such as epidermal growth factor receptor (EGFR) could provide potential target(s) to be explored against malignancies, including NSCLC.